WANY
BIIB icon

Wealthspire Advisors (New York)’s Biogen BIIB Stock Holding History

Wealthspire Advisors (New York)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Sell
1,209
-842
-41% -$155K ﹤0.01% 827
2025
Q4 		$361K Buy
2,051
+984
+92% +$161K ﹤0.01% 725
2025
Q3 		$149K Buy
+1,067
New +$144K ﹤0.01% 886
2025
Q1 		– Sell
-1,712
Closed -$262K – 796
2024
Q4 		$262K Sell
1,712
-184
-10% -$31K ﹤0.01% 674
2024
Q3 		$368K Sell
1,896
-124
-6% -$25.9K ﹤0.01% 575
2024
Q2 		$468K Sell
2,020
-61
-3% -$13.3K 0.01% 448
2024
Q1 		$449K Sell
2,081
-299
-13% -$70K 0.01% 442
2023
Q4 		$616K Buy
2,380
+11
+0.5% +$2.7K 0.01% 387
2023
Q3 		$609K Buy
+2,369
New +$634K 0.01% 357
2023
Q1 		– Sell
-934
Closed -$259K – 542
2022
Q4 		$259K Buy
+934
New +$264K ﹤0.01% 485
2021
Q2 		– Sell
-1,589
Closed -$445K – 403
2021
Q1 		$445K Buy
1,589
+240
+18% +$64.7K 0.01% 427
2020
Q4 		$330K Buy
1,349
+48
+4% +$12.4K 0.01% 406
2020
Q3 		$369K Buy
1,301
+89
+7% +$24.8K 0.02% 213
2020
Q2 		$324K Sell
1,212
-2,245
-65% -$675K 0.02% 196
2020
Q1 		$1.09M Buy
3,457
+2,454
+245% +$745K 0.05% 181
2019
Q4 		$298K Buy
1,003
+94
+10% +$26.1K 0.02% 149
2019
Q3 		$212K Buy
+909
New +$212K 0.02% 152
2019
Q1 		– Sell
-189
Closed -$57K – 138
2018
Q4 		$57K Buy
+189
New +$60.3K 0.01% 167

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wealthspire Advisors (New York)'s BIIB Position: Q1 2026 in Review

Wealthspire Advisors (New York) reduced its Biogen (BIIB) stake by 41% in Q1 2026, selling an estimated $155K and leaving 1,209 shares worth $222K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Wealthspire Advisors (New York) first reported a position in BIIB in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.09M in Q1 2020. 1,005 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Wealthspire Advisors (New York) held 1,209 shares of Biogen worth $222K as of Q1 2026.
  • Wealthspire Advisors (New York) sold 842 Biogen shares in Q1 2026, an estimated $155K.
  • Biogen made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #827 holding.
  • Wealthspire Advisors (New York) first reported a position in Biogen in Q4 2018 and has held it in 18 quarters since.
  • Wealthspire Advisors (New York)'s Biogen position peaked at $1.09M in Q1 2020.
  • 1,005 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.